Medicinal Product Shortages - update - 23 November 2022

Notice type: Advisory

Date: 23/11/2022

 

Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Adizem-XL 120mg Prolonged Release Capsules - PA1688/001/004
  • Adizem-XL 180mg Prolonged Release Capsules - PA1688/001/005
  • Atenomel 50mg Tablets - PA0126/069/001
  • Atorvastatin Clonmel 80mg Film Coated Tablets - PA0126/271/004
  • Brolene 0.1% w/v Eye Drops Solution - PA0126/357/001
  • Brolene 0.15% w/w Eye Ointment - PA0126/357/002
  • Calcichew 500mg Chewable Tablets - PA2239/013/001
  • Clarithromycin 500mg Film Coated Tablets - PA2315/136/004
  • Clonactil 25mg Film Coated Tablets - PA0126/026/003
  • Ixprim 37.5mg/325mg Effervescent Tablets - PA2242/006/002
  • Klaram LA 500mg Prolonged Release Tablets - PA2315/133/001
  • Medispray Oromucosal Spray, Chlorhexidine digluconate 2mg/ml Lidocaine hydrochloride 0.5mg/ml - PA0126/300/001
  • Milrinone 1mg/ml Solution for Injection/Infusion - PA0281/244/001
  • Mydrilate 0.5% Eye Drops - PA22709/003/001
  • Mydrilate 1.0% Eye Drops - PA22709/003/002
  • Quofenix 450mg Tablets - EU/1/19/1393/002

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Actilyse 20mg Powder and Solvent for Solution for Injection and Infusion - PA0775/011/002
  • Azromax 250mg Film Coated Tablets - PA0577/122/001
  • Canesten Thrush Cream - PA1410/039/012
  • Caverject 20mcg Powder and Solvent for Solution for Injection - PA0822/115/003
  • Concerta XL 36mg Prolonged Release Tablets - PA22612/002/002
  • Cytarabine 20mg/ml Solution for Injection or Infusion - PA0822/200/001
  • Ezetimibe/Simvastatin 10mg/80mg Tablets - PA0577/180/003
  • Glycerol Suppositories BP for Adults - PA0549/028/003
  • Macrolief 13.8g Sachet, Powder for Oral Solution - PA0711/224/001
  • Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops - PA23259/011/001
  • Nasacort 55mcg/dose Nasal Spray - PA23180/001/001
  • Pregabalin Sandoz 25mg Capsules - EU/1/15/1011/003,5
  • Pregabalin Sandoz 50mg Capsules - EU/1/15/1011/013
  • Provigil 100mg Tablets - PA0749/198/001
  • Rifadin 300mg Capsules - PA540/066/002
  • Stemetil 12.5mg/ml Solution for Injection - PA0540/127/002
  • Subutex 2mg Sublingual Tablets - PA22617/001/002
  • Tavanic 5mg/ml Solution for Infusion - PA0540/077/001
  • Yasmin 0.03mg/3mg Film Coated Tablets - PA1410/023/001
  • Ziagen 20mg/ml Oral Solution - EU/1/99/112/002
  • Zydol 50mg Hard Capsules - PA2242/005/001

 

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.




« Back